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BRIEF REPORT
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Abstract Thunderclap headache (TCH) can have several
causes of which subarachnoid hemorrhage (SAH) is most
common and well known. A rare cause of TCH is the
reversible cerebral vasoconstriction syndrome (RCVS)
which is characterized by a reversible segmental vaso-
constriction of the intracranial vessels. We describe two
patients with TCH due to RCVS and the probable precip-
itating factor, namely, cannabis and an anti-migraine drug.
In RCVS, cerebrospinal fluid examination is (near) normal,
in contrast to SAH and (primary) cerebral vasculitis. Brain
MRI may be normal or shows infarction. MRA can dem-
onstrate vasoconstriction of the great arteries, but a normal
MRA does not rule out the diagnosis. Caliber changes on
cerebral angiography cannot adequately differentiate
between RCVS and vasculitis. Calcium-channel antago-
nists may be a good therapy and repeated transcranial
Doppler ultrasonography can be a reliable non-invasive
investigation to monitor the effect of treatment and dem-
onstrate reversibility of the vasoconstriction.
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Introduction
Thunderclap headache (TCH) is often associated with a
subarachnoid hemorrhage (SAH). However, TCH can also
be the first sign of several other neurological conditions,
some of which are less well known [1]. The term primary
TCH can be used when all other potential conditions have
been eliminated by diagnostic testing. A rare cause of TCH
is the reversible cerebral vasoconstriction syndrome
(RCVS) [2]. This syndrome is characterized by a reversible
segmental vasoconstriction of the intracranial blood vessels
[2–5]. It is important to recognize this syndrome and dis-
tinguish RCVS from other conditions such as primary
angiitis of the central nervous system (PACNS), to choose
proper treatment [3, 4, 6]. Here, we present two patients
with TCH due to RCVS and discuss the clinical features of
this often unrecognized syndrome.
Case 1
A 46-year-old man with a history of radical extirpated
melanoma was transferred to our hospital under the sus-
picion of cerebral vasculitis. One week before, he
presented with spontaneous acute severe headache, fol-
lowed a few days later by progressive confusion and a mild
left-sided hemiparesis. Magnetic imaging resonance (MRI)
of the brain showed ischemic lesions bilateral occipital and
right parietal. MR angiography (MRA) showed no abnor-
mality; however, on second review the examination was
without gadolinium and of poor quality and therefore not
reliable. Patient did not use any medication, smoked 20
cigarettes and 3–4 times cannabis a day. The admission
blood pressure was 184/89 and the following day 154/90.
On neurological examination, he appeared confused and
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scored 15 of 30 items on the mini-mental state examina-
tion. There was a hemiparesis MRC grade 4 on the left
side. Ancillary laboratory investigations in serum (includ-
ing blood count, serum electrolytes, liver, renal and thyroid
function tests, erythrocyte sedimentation rate, C-reactive
protein level, antinuclear and antineutrophil cytoplasmic
antibody tests, complement C1q, C3 and C4, lupus anti-
coagulant, rheumatoid factor) and cerebrospinal fluid
(CSF) showed no abnormalities. Selective catheter cerebral
angiography showed multiple caliber changes in the
intracranial blood vessels (Fig. 1). Transcranial Doppler
ultrasonography (TCD) examination showed increased
intracranial blood flow velocities among others of medial
cerebral artery (154 cm/s), and anterior cerebral artery
(168 cm/s). Because of the acute presentation with TCH,
normal CSF examination and the findings on TCD the
diagnosis RCVS was established. Calcium-channel antag-
onist nimodipine 60 mg six times daily was started. Few
days after treatment was started, the clinical condition
improved. A follow-up TCD showed a normalization of
blood flow velocities (medial cerebral artery: 94 cm/s and
anterior cerebral artery: 90 cm/s). The follow-up MRI
showed reduction in size of the hyperintense lesions. The
patient was transferred to a rehabilitation center and dis-
charged home after 3 weeks under good clinical condition.
Case 2
A 48-year-old woman presented at the emergency depart-
ment with spontaneous acute severe headache. She had a
history of migraine, but did not recognize this type of
headache as her migraine headache. She frequently used
sumatriptan and 1 week before admission, because of
severe attacks, she had used sumatriptan daily with tem-
porally good response. On examination, the blood pressure
was 140/88 and neurological examination was normal. SAH
was ruled out by CT scan and CSF examination was com-
pletely normal. Following day, she became confused with
behavioral changes. Brain MRI/MRA revealed no abnor-
malities. TCD showed increased blood flow velocities over
the medial cerebral artery (109 cm/s) and anterior cerebral
artery (108 cm/s). Under the suspicion of RCVS, calcium
antagonist verapamil 120 mg twice daily was started.
Within a day, the patient improved clinically and TCD after
4 days showed normal blood flow velocities of medial
cerebral artery (80 cm/s) and anterior cerebral artery
(66 cm/s). She was discharged at home without any com-
plaints and was strongly advised not resume any triptans.
Discussion
These cases highlight the recognition of RCVS as a cause
of TCH. It is important to realize that TCH is a symptom
rather than a diagnosis and can be caused by several acute
(neurological) conditions as cerebral venous thrombosis,
ischemic stroke, dissection, acute hypertension, vasospasm
and infection [1].
The RCVS was first described by Call et al. in 1988 [2]
and is characterized by a reversible segmental vasocon-
striction of the intracranial vessels. It is most common in
women aged 20–50 years. The striking presenting feature
of RCVS is TCH, followed immediately, or after a symp-
tom free interval, by seizures, neurological deficits or
encephalopathy [2–5]. RCVS can occur spontaneously or
in association with pregnancy, migraine, sexual activity,
certain prescribed or illicit drugs (selective serotonin re-
uptake inhibitors, triptans, cannabis, cocaine and ecstasy)
[3–5, 7–10]. Concerning the patients in our case, the fre-
quent use of cannabis in the first patient and sumatriptan in
the second patient were probably the precipitating factors.
Fig. 1 Cerebral angiography:
multiple caliber changes in the
intracranial vessels
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MRI findings in RCVS can be normal or showing
ischemic lesions, especially in posterior circulation and
watershed areas. CSF is normal in 80–90% of the patients,
as it was in our patients [3–6].
MR angiography can demonstrate vasoconstriction in
the proximal parts of the great cerebral arteries. However, a
normal MRA examination does not rule out the diagnosis.
In a series of 44 RCVS patients, 6 had a normal MRA
while on cerebral angiography there were signs of vaso-
constriction [7]. In the first patient MRA was inconclusive
but cerebral infarction was seen on MRI and cerebral
angiography showed multiple alterations. MRA in the
second patient did not show vasospasm; the reason might
be that this patient had only mild vasospasm.
Cerebral angiography can show multiple alterations of
the cerebral blood vessel caliber. These findings are often
associated with cerebral vasculitis or PACNS but these
patients present in general with gradually progressive
neurological symptoms, encephalopathy and CSF is
abnormal in 80–90% [1, 6, 11].
TCD is not specific for the initial diagnosis of RCVS,
but (repeated) TCD can be a reliable non-invasive inves-
tigation to monitor vasospasm. Normalization of cerebral
blood flow velocities is often seen within 12 weeks [5, 12].
In our patients there was also normalization of cerebral
blood flow velocities.
The exact pathophysiology underlying the reversible
vasoconstriction is unknown. The International Classifica-
tion of Headache Disorders-II classified RCVS as a
secondary headache disorder, in contrast to primary TCH.
Alternatively, Chen et al. suggested that primary TCH, or
TCH elicited by, e.g., physical stress and RCVS are dif-
ferent spectra of the same disorder. Their study showed
vasospasm in 39% of the patients with recurrent primary
TCH [13]. This suggests that RCVS may have a higher
incidence than reported earlier.
The sympathetic nervous system may play a role in the
pathogenesis of TCH. This is suggested by the fact that
TCH has been associated with factors elevating sympa-
thetic tone, such as adrenergics and physical stress [14].
Furthermore, proximal parts of the intracranial vessels are
strongly innervated by sympathetic afferents, which mod-
ulate vascular tone. Vasoconstriction in RCVS is most
common in these large- and medium-sized vessels [1, 4].
In RCVS, there is no established therapy. A few small
observational studies and case reports described a good
effect of calcium-channel antagonists in the treatment of
the vasospasm of intracranial vessels [3, 15]. In summary,
TCH is a symptom which can be caused by several (neu-
rological) conditions. A normal brain CT scan and CSF
examination can exclude a SAH but are not sufficient to
establish ‘‘primary TCH’’. A rare cause of TCH is RCVS.
The exact cause of RCVS is unknown but among others
associated with substance and medication use. Sometimes,
this syndrome can be difficult to distinguish from PACNS
on cerebral angiography and can be a pitfall. The acute
presentation with TCH and the normal CSF examination
are in favor of RCVS. Calcium-channel antagonists like
nimodipine may be a good therapy and repeated TCD can
be a reliable non-invasive investigation to monitor the
effect of treatment and demonstrate the reversibility.
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